Clinical Trial Update: Study of PlasmaCap IG in Adults and Children With PIDD [Phase 3]

View source ↗

Summary

A Phase 3 trial update for PlasmaCap IG in adults and children with primary immune deficiency diseases (PIDD) is reported, but current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Deficiency Diseases

Drugs mentioned

• PlasmaCap IG (PlasmaCap IG)

Snippet

Sponsor: Evolve Biologics | Conditions: Primary Immune Deficiency Diseases (PIDD) | Phase 3 | Status: UNKNOWN